A.J. Pruitt, technology manager at Accumold discusses the impact of the company’s successful drive towards the efficient micromoulding of previously extruded thin walled cannulas, and what this means for industry.  Q. Can you explain...

Biotechnology companies and research organisations in the UK and Canada are entering into a R&D project jointly funded by a 1.1 million GBP grant from Innovate UK and the National Research Council of Canada...

Viacheslav Vasylenko, Сo-Founder & Chief Operating Officer, Viseven discusses digital content factories and why they are essential for pharma companies today. Modern pharma brands pursue a higher degree of content personalisation to engage with...

QuantaMatrix has unveiled what it’s calling “the world’s fastest” all-in-one antimicrobial testing technology. The uRAST (ultra-rapid antimicrobial susceptibility testing) solution has recently been published in the scientific journal, Nature. Traditionally, antimicrobial testing methods can...

Maruho Hatsujyo Innovations (MHI) will showcase a blister machine specifically intended for stability testing, clinical trials and similar small-run applications at Pack Expo Booth W-15058, 3-6th November in Chicago. The Eagle-LP – short for “Lab...

AstraZeneca and Daiichi Sankyo have announced that the duo’s antibody-drug conjugate (ADC), Enhertu (trastuzumab deruxtecan), has received conditional approval from the China National Medical Products Administration (NMPA) for gastric cancer. Now, Enhertu can be used as...

Oncimmune Holdings plc, a leading autoantibody profiling company providing research services to the pharmaceutical and biotechnology industry to enable the delivery of precision medicine, has announced a new contract win with a top 10...

Amneal Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its CREXONT extended-release capsules for Parkinson’s disease (PD) treatment. The oral carbidopa (CD)/levodopa (LD) formulation that makes up CREXONT aims...

Kerato has entered into a Heads of Terms agreement and research partnership with the University of Montreal in Canada. BSF’s 100% owned Kerato is an independent company established to commercialise new innovations in tissue...

Atopic dermatitis (AD) is experiencing a transformative shift in treatment management with recent drug approvals that address critical unmet needs. The introduction of novel therapies, such as Dermavant’s VTAMA (tapinarof) (Japan) and Arcutis’s ZORYVE...

OncoHost has announced that three of its research abstracts have been selected for presentation at the upcoming World Conference on Lung Cancer (WCLC 2024). The abstracts highlight OncoHost’s work in developing predictive models for immunotherapy-related...

NorthStar Medical Radioisotopes (NorthStar) and Convergent Therapeutics (Convergent) are set to expand its collaboration relating to the CONV01-a treatment for prostate cancer. The duo explains its new drug by detailing that “CONV01-a is a prostate-specific membrane antigen-targeted...

Lykos Therapeutics (Lykos) has received a rejection from the US Food and Drug Administration (FDA) regarding its midomafetamine (MDMA) treatment for post-traumatic stress disorder (PTSD). Upon rejecting the treatment due to the “data submitted...

Pharmaceutical companies bidding for the newly launched NHS Antimicrobial Product subscription model will be required to demonstrate the steps they are taking to promote responsible antibiotic manufacturing and minimise the risk of antimicrobial resistance...

Champalimaud Foundation has decided to install one of Lonza’s MODA-ES Platforms at its Champalimaud Clinical Centre in Lisbon, Portugal. The biomedical clinical research organisation has opted to install MODA-ES as it hopes to improve...

Alcura, a provider of specialised clinical trial services and a part of Cencora, has been granted a Manufacturing and Importation Authorization (MIA) license for cell and gene therapies (CGT) by the Spanish Agency of...

Beckman Coulter Life Sciences offers a new approach to oncology research. The Illumina TruSight Oncology 500 DNA/RNA assay on the Biomek NGeniuS System from Beckman Coulter Life Sciences provides an innovative automated solution enabling comprehensive genomic...